Risk Factors for an Early Increase in Dose of Vasoactive Agents for Intracavernous Pharmacotherapy

Publisher： Karger

E-ISSN： 1423-0399|65|4|204-207

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.65, Iss.4, 2000-11, pp. : 204-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cavernositis following Intracavernous Injection of Vasoactive Drugs

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Risk Factors for Early Failure of Native Arteriovenous Fistulas

By  

Nephron Clin Pract, Vol. 101, Iss. 1, 2005-05 ,pp. : c39-c44

Karger

Access to resources Recommend Favorite

Long‐term, low‐dose exposure to microcystin toxin does not increase the risk of liver tumor development or growth in mice

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 683-692

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perinatal risk factors increase the risk of being affected by both type 1 diabetes and coeliac disease

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 2, 2015-02 ,pp. : 178-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Administration of Perflutren Contrast Agents during Transthoracic Echocardiography Is Not Associated with a Significant Increase in Acute Mortality Risk

By  

Cardiology, Vol. 122, Iss. 2, 2012-07 ,pp. : 119-125

Karger

Access to resources Recommend Favorite